Nature Reviews Disease Primers

Nature Reviews Disease Primers is a premier, peer-reviewed journal published by Springer Nature, dedicated to providing authoritative, comprehensive overviews of major diseases and medical conditions. With an ISSN of 2056-676X and an exceptional 2026 Impact Factor of 79.800, the journal is consistently ranked in the top Q1 quartile of both the Medicine, General & Internal and Clinical Neurology categories, reflecting its unparalleled influence in the medical literature. The journal’s scope encompasses a broad range of diseases, from common chronic illnesses to rare genetic disorders, with each “Primer” offering a holistic, multi-disciplinary synthesis of the current state of knowledge. Articles are exclusively invited reviews, known as Primers, which systematically cover the epidemiology, mechanisms, diagnosis, prevention, and management of a given condition, often including expert perspectives on quality of life and future research directions. These Primers are authored by leading international clinicians and scientists, ensuring rigorous, evidence-based content. The target audience includes clinical practitioners, medical researchers, public health professionals, and advanced students seeking a deep yet accessible understanding of disease landscapes. A notable feature is the journal’s open access model, ensuring global accessibility to its high-impact content, which is further enhanced by accompanying visual abstracts and patient-focused summaries. By distilling complex, rapidly evolving fields into definitive, citable resources, Nature Reviews Disease Primers serves as an essential reference tool and a benchmark for excellence in translational medicine and clinical science.